Cancer
TGF-b 131-139 (HLA-A*02:01) RLSSCVPVA
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP11436_1
Description
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed TGF-beta receptor type-2-derived peptide of RLSSCVPVA sequence covering 131-139 and A*02:01 molecule. The peptide provided here is unlabelled or fluorescent labelled, such as Biotin, R-PE, APC. All products are available in 50, 150 and 500 tests.
TechData
| Sequence: | RLSSCVPVA |
| Gene: | TGFBR2 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | TGF-beta receptor type-2 |
| UniProt Id: | P37173 |
| IEDB Id: | 1310187 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |